DRUGS AND LIVER DISEASE
A. E. Read I propose to review the important relationships between the liver and drug therapy, and I ask you to excuse me if my delivery is a simple one as 1 realize that an audience such as this is not necessarily interested in the finer points of this subject. Briefly the ways in which drugs and liver disease are involved are as follows:? Some drugs damage the liver; most drugs undergo metabolic change within the liver and their metabolism may be abnormal in liver disease; and drugs are known to have unusual and sometimes dangerous side effects in the presence of liver disease.
First I shall deal with liver disease due to drugs, which may be summarized thus:?
Liver damage due to drugs, etc. The part of the liver injured and the mechanisms involved are variable, but it is convenient to classify these reactions firstly as those affecting the biliary apparatus, producing obstructive jaundice either " cholestatic" or " cholangiolitic "; secondly, as drug lesions which affect the liver cell, and which produce either liver cell jaundice or liver cell failure, depending on the intracellular site of the damage, or the extent to which whole liver cells are destroyed. An The effects of various poisons are as follows: Briefly there is a predominance of fatty infiltration, a tendency for zonal change (probably related to varying enzyme susceptibility), and damage in several organs other than the liver. Recently it has been shown that the lesion involves destruction of fatty acids making up the smooth endoplasmic reticulum, by the poison or one of its metabolic products (Hashimoto, Glende and Recknagel, 1968) . These fatty acids undergo lipid peroxidation, and it is of interest that various factors and certain drugs affect the severity of this process. I have illustrated this in Fig. 2 where I have tried to distinguish between a direct hepatic poison and an indirect one. Carbon tetrachloride is an example of the latter type, for the toxicity of carbon tetrachloride resides in a metabolic breakdown product and not in the poison itself. The production of the toxin will depend on the action of drug-modifying enzymes which one would expect to be diminished in concentration when there is liver disease or protein deficiency; so under these circumstances carbon tetrachloride might be less toxic than in normals. Certainly this is demonstrable in the protein-deficient rat and spider naevi. One must also remember that protein binding may be affected by liver disease and in certain circumstances this may also modify the effect of drugs.
There is a general impression that drug metabolism is slower in liver disease. Fig. 3 , taken from the paper by Levi (1967) (Shear, Bonokowsky, and Gabuzda, 1969) , namely renal tubular acidosis of the acquired type may, by increasing renal ammonia production, facilitate the development of hyperammonaemia and encephalopathy, or at least partially explain the fact that certain diuretics will produce a similar effect. Similar abnormalities of function in other organs may explain other abnormalities of drug action.
1 have suggested to you that we know next to nothing about drug activity in normal subjects and its genetic variations. We know even less, if that is possible, about drug metabolism in the face of dysfunction in the liver or indeed in any other organ.
